1 Min Read
March 14 (Reuters) - Impax Laboratories Inc:
* AMNEAL PHARMACEUTICALS SAYS RECEIVED FDA APPROVAL FOR ERYTHROMYCIN TABLETS USP, 250 MG AND 500 MG STRENGTHS Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.